StrainScan Pro is being positioned for portable enterprise use across farming and post-harvest operations as Medical Care Technologies targets agricultural applications for its proprietary AI vision technology.
Key Investor Takeaways – Medical Care Technologies (USOTC:MDCE) is expanding StrainScan Pro into agricultural quality control, adding another potential commercial vertical for its AI vision platform. – The software is designed to run on iPad Air devices, allowing visual grading and produce inspection in fields, packing facilities and post-harvest environments without complex fixed infrastructure. – Management points to a global agricultural production market estimated near $5 trillion, although the company did not provide a specific revenue target or customer deployment figure. – The expansion could broaden the commercial positioning of MDCE’s proprietary technology while its Infinite Auctions and Real Game Used subsidiaries continue to provide revenue-generating operations. – Investor attention may now shift toward evidence of enterprise adoption and whether agricultural deployments translate the platform’s addressable-market opportunity into commercial traction
Why MDCE Stock Is in Focus Medical Care Technologies (USOTC:MDCE) is expanding StrainScan Pro into agricultural quality control, positioning its proprietary AI vision software for enterprise deployment on iPad Air devices. The platform performs on-device visual analysis and is designed to support quality grading and produce inspection at multiple points in agricultural operations, including directly in the field, at packing facilities and during post-harvest handling. The iPad Air deployment model is significant to the company’s commercial approach because it is intended to provide portable inspection capabilities without requiring complex fixed infrastructure.
Medical Care Technologies cited global agricultural production value estimated near $5 trillion as the broader market backdrop for the…